Vertex Pharmaceuticals VRTX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.34B+9.7% | $3.95B— | —— | —— | —— | ||
| $217.3M+3.6% | $209.8M+4.6% | $200.6M+0.4% | $199.8M-1.1% | $202.1M-2.5% | ||
| $686.2M0.0% | $685.9M-1.5% | $696.1M+1.5% | $685.8M+1.9% | $672.7M-3.7% | ||
| $4.24B+16.8% | $3.63B+20.6% | $3.01B+82.9% | $1.65B+152% | -$3.18B-18.1% | ||
| $530.3M+21.2% | $437.6M+14.9% | $380.8M+9.8% | $346.7M+28.4% | $270M-9.3% | ||
| -$1.32B-39.8% | -$945.4M+36.1% | -$1.48B+13.5% | -$1.71B-1.2% | -$1.69B+55.2% | ||
| $1.93B-4.4% | $2.02B-12.5% | $2.31B+49.5% | $1.54B+4.9% | $1.47B+25.1% | ||
| -$2.12B+6.3% | -$2.26B+12.2% | -$2.58B-42.4% | -$1.81B+0.5% | -$1.82B-21.6% | ||
| $853.7M+55.3% | $549.8M+307% | -$266.1M— | —— | —— | ||
| $3.71B+16.2% | $3.19B+20.6% | $2.65B+102% | $1.31B+138% | -$3.44B-15.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vertex Pharmaceuticals generate?
- Vertex Pharmaceuticals (VRTX) generated $4.2B in operating cash flow over the trailing twelve months.
- What is Vertex Pharmaceuticals's free cash flow?
- After $530.3M of capital expenditures, Vertex Pharmaceuticals's free cash flow was $3.7B over the trailing twelve months, up 207.9% year over year.
- Where does Vertex Pharmaceuticals's cash flow data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
